These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2692895)

  • 41. Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogeneous autoantibody profiles in human autoimmune sera.
    Guldner HH; Netter HJ; Szostecki C; Lakomek HJ; Will H
    J Immunol; 1988 Jul; 141(2):469-75. PubMed ID: 2454993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ENA: its place in medicine.
    Reichlin M
    Lupus; 2002; 11(4):201-3. PubMed ID: 12043881
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
    Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
    Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
    [No Abstract]   [Full Text] [Related]  

  • 44. The SL/Ki system in connective tissue diseases: incidence and clinical associations.
    Riboldi P; Asero R; Origgi L; Crespi S
    Clin Exp Rheumatol; 1987; 5(1):29-33. PubMed ID: 3594962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Demonstration of autoantibodies against extractable nuclear antigens(ENA) in immunoenzyme assay (ELISA) and in transmigratory electrophoresis].
    Kühl R; Sachs V; Töpfer A
    Beitr Infusionther Klin Ernahr; 1987; 18():389-92. PubMed ID: 3326596
    [No Abstract]   [Full Text] [Related]  

  • 46. SLE or MCTD and the snurp in the splicing.
    Whittingham S
    J Rheumatol; 1990 Oct; 17(10):1260-2. PubMed ID: 1701487
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical importance of antibodies against double-stranded ribonucleic acid in systemic lupus erythematosus and similar diseases of connective tissue.
    Cebecauer L; Rovenský J; Poverenny AM; Podgorodnichenko VK; Doskocil J; Zitnan D
    Czech Med; 1979; 2(3):134-40. PubMed ID: 535500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases.
    Decker P; Briand JP; de Murcia G; Pero RW; Isenberg DA; Muller S
    Arthritis Rheum; 1998 May; 41(5):918-26. PubMed ID: 9588745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 3) Mixed connective tissue disease].
    Nishimaki T; Kasukawa R
    Nihon Rinsho; 1988 Apr; 46(4):879-82. PubMed ID: 3404708
    [No Abstract]   [Full Text] [Related]  

  • 50. Connective tissue disease antibodies and pregnancy.
    Scott JS
    Am J Reprod Immunol (1980); 1984; 6(1):19-24. PubMed ID: 6433733
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases.
    Galperin C; Coppel RL; Gershwin ME
    Int Arch Allergy Immunol; 1996 Dec; 111(4):337-47. PubMed ID: 8957106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cross-reactivity of autoantibodies in connective tissue diseases.
    Caponi L
    Clin Exp Rheumatol; 1996; 14(4):425-31. PubMed ID: 8871844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear protein antigens in autoimmune rheumatic and connective tissue diseases.
    MacGillivray AJ; Dahi S; Naxakis G; Wallis CM
    Cell Biol Int Rep; 1981 Jan; 5(1):69-72. PubMed ID: 6784934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cascade testing for autoantibodies in connective tissue diseases.
    Homburger HA
    Mayo Clin Proc; 1995 Feb; 70(2):183-4. PubMed ID: 7845044
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular mimicry and autoantigens in connective tissue diseases.
    Horsfall AC
    Mol Biol Rep; 1992 Jun; 16(3):139-47. PubMed ID: 1380637
    [No Abstract]   [Full Text] [Related]  

  • 56. Analysis of anti-U1 RNA antibodies in patients with connective tissue diseases: comment on the article by Hoffman et al.
    van den Hoogen FH; Boerbooms AM; van de Putte LB
    Arthritis Rheum; 1996 Jul; 39(7):1265-6. PubMed ID: 8670346
    [No Abstract]   [Full Text] [Related]  

  • 57. Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders.
    Murakami K; Mimori T
    Intern Med; 2019 Jan; 58(1):5-14. PubMed ID: 30146596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mixed immunofluorescence findings in mixed connective tissue disease.
    Nunzi E; Parodi A; Rebora A
    Clin Exp Dermatol; 1982 Sep; 7(5):485-9. PubMed ID: 6756713
    [No Abstract]   [Full Text] [Related]  

  • 59. [Correction of immunologic reactivity depending on ABO system antigens in patients with purulent infections of soft tissue and shigellosis].
    Zemskov AM; Zemskov VM; Vornovskiĭ VA; Salomakhin GG; Vysotskaia AT
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (1):75-7. PubMed ID: 11236513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Connective tissue diseases: Autoantibodies to PDGFR are profibrotic in vivo.
    Onuora S
    Nat Rev Rheumatol; 2016 Jun; 12(6):316. PubMed ID: 27170512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.